Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Sharma, Ruchi ^a   Buras, Eric ^a   Terashima, Tomoya ^a   Serrano, Faridis ^a   Massaad, Cynthia A ^a   Hu, Lingyun ^a   Bitner, Brittany ^a   Inoue, Taeko ^a   Chan, Lawrence ^a   Pautler, Robia G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STREPTOZOCIN; SUPEROXIDE; TAU PROTEIN; PRIMER DNA; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; GENE OVEREXPRESSION; HYPERGLYCEMIA; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE FIBER TRANSPORT; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; TRANSPORT KINETICS; WILD TYPE; ANIMAL; METABOLISM; NERVE FIBER; NUCLEOTIDE SEQUENCE; OLFACTORY RECEPTOR;

MUS;

ANIMALS; AXONS; BASE SEQUENCE; DNA PRIMERS; HYPERGLYCEMIA; MAGNETIC RESONANCE IMAGING; MICE; OLFACTORY RECEPTOR NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 78149431472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013463     Document Type: Article

References (35)

1. Menne J, Park J-K, Boehne M, Elger M, Lindschau C, et al. (2004) Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 53: 2101-2109.
2. Vincent AM, Kato K, McLean LL, Soules ME, Feldman EL (2009) Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid Redox Signal 11: 425-438.
3. Dennis JC, Coleman ES, Swyers SE, Moody SW, Wright JC, et al. (2005) Changes in mitotic rate and GFAP expression in the primary olfactory axis of streptozotocin-induced diabetic rats. J Neurocytol 34: 3-10.
4. Le Floch JP, Le Lievre G, Labroue M, Paul M, Peynegre R, et al. (1993) Smell dysfunction and related factors in diabetes. Diabetes Care 16: 934-937.
5. Weinstock RS, Wright HN, Smith DU (1993) Olfactory dysfunction in diabetes mellitus. Physiol Behav 53: 17-21.
6. Smith KD, Kallhoff V, Zheng H, Pautler RG (2007) In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 35: 1401-1408.
7. Massaad C, Amin S, Hu L, Mei Y, Klann E, et al. (2010) Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's Disease. PloSOne 10;5(5): e10561.
8. Brownlee M (2005) The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615-1625.
9. Tomlinson DR (2008) Diabetic neuropathies: components of etiology. J Peripher Nerv Syst 13: 112-121.
10. Vincent AM, Russell JW, Sullivan KA, Backus C, Hayes JM, et al. (2007) SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp Neurol 208: 216-277.
11. Price SA, Agthong S, Middlemas A, Tomlinson DR (2004) Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy. Diabetes 53: 1851-1856.
12. Purves T, Middlemas A, Agthong S, Jude ED, Boulton AJM, et al. (2001) A role of mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB 15: 2508-2514.
13. Sithiporn A, David R T (2002) Inhibition of p38 map kinase corrects biochemical and neurological deficits in experimental diabetic neuropathy. Ann N Y Acad Sci 973: 359-362.
14. Oh-Hashi K, Maruyama W, Isobe K (2001) Peroxynitrite induces GADD34, 45, and 153 via p38 MAPK in human neuroblastoma SH-SY5Y cells. Free Radic Biol Med 30: 213-221.
15. Burnett KR, Goldstein EJ, Wolf GL, Sen S, Mamourian AC (1984) The oral administration of MnCl2: a potential alternative to IV injection for tissue contrast enhancement in magnetic resonance imaging. Magn Reson Imaging 2: 307-314.
16. Narita K, Kawasaki F, Kita H (1990) Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res 510: 289-295.
17. Pautler RG, Silva AC, Koretsky AP (1998) In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 40: 740-748.
18. Cross DJ, Flexman JA, Anzai Y, Maravilla KR, Minoshima S (2008) Age-related decrease in axonal transport measured by MR imaging in vivo. Neuroimage 39: 915-926.
19. Tindemans I, Verhoye M, Balthazart J, VDL A (2003) In vivo dynamic MEMRI reveals differential functional responses of RA- and area X-projecting neurons in the HVC of canaries exposed to conspecific song. Eur J Neurosci 18: 3352-3360.
20. Pautler RG (2004) In vivo trans-synaptic tract-tracing utilizing manganese enhanced magnetic resonance imaging (MEMRI). NMR Biomed 17: 595-601.
21. Pautler RG, Mongeau R, Jacobs RE (2003) In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI). Magn Reson Med 50: 33-39.
22. Sloot WN, Gramsbergen JP (1994) Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Research 657.
23. Hu D, Serrano F, Oury T, Klann E (2006) Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J Neurosci 26: 3933-3941.
24. Ho Y-S, Vincent R, Dey MS, Slot JW, Crapo JD (1998) Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 18: 538-547.
25. Hough S, Russell JE, Teitelbaum SL, Avioli LV (1982) Calcium homeostasis in chronic streptozotocin-induced diabetes mellitus in the rat. Am J Physiol 242: 451-E456.
26. Levy J (2007) Abnormal cell calcium homeostasis in type 2 diabetes mellitus. Endocrine 10: 1-6.
27. Jagodic MM, Pathirathna S, Nelson MT, Mancuso S, Joksovic PM, et al. (2007) Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci 27: 3305-3316.
28. Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, et al. (2000) Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Res 878: 218-222.
29. Munusamy S, MacMillan-Crow LA (2009) Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells. Free Radic Biol Med 46: 1149-1157.
30. Kowluru RA, Kowluru V, Xiong Y, Ho Y-S (2006) Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetesinduced oxidative stress. Free Radic Biol Med 41: 1191-1196.
31. Shen X, Zheng S, Metreveli NS, Epstein PN (2006) Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 55: 798-805.
32. Clodfelder-Miller BJ, Zmijewska AA, Johnson GVW, Jope RS (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55: 3320-3325.
33. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, et al. (2007) Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27: 13635-13648.
34. Terwel D, Dewachter I, Leuven FV (2002) Axonal transport, tau protein, and neurodegeneration in Alzheimer's Disease. Neuromolecular Med 2: 151-165.
35. Chen H, Brahmbhatt S, Gupta A, Sharma AC (2005) Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction. Cardiovasc Diabetol 4: 3.